SNTI Senti Biosciences Inc.

Price (delayed)

$1.005

Market cap

$31.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.87

Enterprise value

$37.98M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 28
Highlights
SNTI's EPS has surged by 83% year-on-year and by 32% since the previous quarter
The revenue has soared by 73% from the previous quarter
Senti Biosciences's equity has shrunk by 93% YoY and by 54% QoQ
The quick ratio has dropped by 74% year-on-year and by 39% since the previous quarter

Key stats

What are the main financial stats of SNTI

SNTI stock price

How has the Senti Biosciences stock price performed over time
Intraday
3.05%
1 week
0.5%
1 month
6.62%
1 year
-70.35%
YTD
-3.37%
QTD
23.77%

Financial performance

How have Senti Biosciences's revenue and profit performed over time
Revenue
$38,000
Gross profit
$38,000
Operating income
-$63.88M
Net income
-$51.55M
Gross margin
100%
Net margin
-135,650%
The revenue has soared by 73% from the previous quarter
SNTI's gross profit has surged by 73% since the previous quarter
The net margin has soared by 51% from the previous quarter
Senti Biosciences's operating margin has increased by 46% QoQ

Price vs fundamentals

How does SNTI's price correlate with its fundamentals

Growth

What is Senti Biosciences's growth rate over time

Valuation

What is Senti Biosciences stock price valuation
P/E
N/A
P/B
12.2
P/S
819.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
999.43
SNTI's EPS has surged by 83% year-on-year and by 32% since the previous quarter
SNTI's P/B is 119% above its last 4 quarters average of 5.4
Senti Biosciences's equity has shrunk by 93% YoY and by 54% QoQ
The revenue has soared by 73% from the previous quarter

Efficiency

How efficient is Senti Biosciences business performance
The ROE has plunged by 184% YoY and by 56% from the previous quarter
SNTI's return on sales has surged by 51% since the previous quarter
The ROA has contracted by 45% YoY
The ROIC is down by 42% year-on-year

Dividends

What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNTI.

Financial health

How did Senti Biosciences financials performed over time
The company's total assets is 7% higher than its total liabilities
SNTI's current ratio has dropped by 75% year-on-year and by 38% since the previous quarter
The quick ratio has dropped by 74% year-on-year and by 39% since the previous quarter
Senti Biosciences's equity has shrunk by 93% YoY and by 54% QoQ
SNTI's debt to equity is up by 44% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.